-
-
-
-
-
-
-
Actuate Announces Upcoming Presentation on Initial Data on Elraglusib in Combination with FOLFIRINOX at the AACR Special Conference on Advances in Pancreatic Cancer Research
-
-
-
-
-
-
-
Form S-1/A ACTUATE THERAPEUTICS,
-
-
69,038 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


